361 related articles for article (PubMed ID: 27194304)
41. Dairy calcium supplementation in overweight or obese persons: its effect on markers of fat metabolism.
Bortolotti M; Rudelle S; Schneiter P; Vidal H; Loizon E; Tappy L; Acheson KJ
Am J Clin Nutr; 2008 Oct; 88(4):877-85. PubMed ID: 18842771
[TBL] [Abstract][Full Text] [Related]
42. Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallel-controlled, double-blinded, diet intervention study.
Bohl M; Bjørnshave A; Rasmussen KV; Schioldan AG; Amer B; Larsen MK; Dalsgaard TK; Holst JJ; Herrmann A; O'Neill S; O'Driscoll L; Afman L; Jensen E; Christensen MM; Gregersen S; Hermansen K
Am J Clin Nutr; 2015 Apr; 101(4):870-8. PubMed ID: 25833983
[TBL] [Abstract][Full Text] [Related]
43. The effects of trans-resveratrol on insulin resistance, inflammation, and microbiota in men with the metabolic syndrome: A pilot randomized, placebo-controlled clinical trial.
Walker JM; Eckardt P; Aleman JO; da Rosa JC; Liang Y; Iizumi T; Etheve S; Blaser MJ; L Breslow J; Holt PR
J Clin Transl Res; 2019 Jan; 4(2):122-135. PubMed ID: 30873501
[TBL] [Abstract][Full Text] [Related]
44. Substrate Metabolism and Insulin Sensitivity During Fasting in Obese Human Subjects: Impact of GH Blockade.
Pedersen MH; Svart MV; Lebeck J; Bidlingmaier M; Stødkilde-Jørgensen H; Pedersen SB; Møller N; Jessen N; Jørgensen JOL
J Clin Endocrinol Metab; 2017 Apr; 102(4):1340-1349. PubMed ID: 28324055
[TBL] [Abstract][Full Text] [Related]
45. No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial.
Kjær TN; Ornstrup MJ; Poulsen MM; Stødkilde-Jørgensen H; Jessen N; Jørgensen JOL; Richelsen B; Pedersen SB
J Clin Endocrinol Metab; 2017 May; 102(5):1642-1651. PubMed ID: 28182820
[TBL] [Abstract][Full Text] [Related]
46. Acute Epigallocatechin 3 Gallate (EGCG) Supplementation Delays Gastric Emptying in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
Fernandes RC; Araújo VA; Giglio BM; Marini ACB; Mota JF; Teixeira KS; Monteiro PA; Lira FS; Pimentel GD
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30127247
[No Abstract] [Full Text] [Related]
47. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients.
Fritsch M; Koliaki C; Livingstone R; Phielix E; Bierwagen A; Meisinger M; Jelenik T; Strassburger K; Zimmermann S; Brockmann K; Wolff C; Hwang JH; Szendroedi J; Roden M
Am J Clin Nutr; 2015 Nov; 102(5):1051-8. PubMed ID: 26423389
[TBL] [Abstract][Full Text] [Related]
48. Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women.
Dostal AM; Arikawa A; Espejo L; Bedell S; Kurzer MS; Stendell-Hollis NR
J Hum Nutr Diet; 2017 Apr; 30(2):166-176. PubMed ID: 27600055
[TBL] [Abstract][Full Text] [Related]
49. Change in postprandial substrate oxidation after a high-fructose meal is related to body mass index in healthy men.
Smeraglio AC; Kennedy EK; Horgan A; Purnell JQ; Gillingham MB
Nutr Res; 2013 Jun; 33(6):435-41. PubMed ID: 23746558
[TBL] [Abstract][Full Text] [Related]
50. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
[TBL] [Abstract][Full Text] [Related]
51. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
Weyer C; Tataranni PA; Snitker S; Danforth E; Ravussin E
Diabetes; 1998 Oct; 47(10):1555-61. PubMed ID: 9753292
[TBL] [Abstract][Full Text] [Related]
52. Resveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial.
Beijers RJ; Gosker HR; Sanders KJ; de Theije C; Kelders M; Clarke G; Cryan JF; van den Borst B; Schols AM
Clin Nutr; 2020 Oct; 39(10):2989-2997. PubMed ID: 31996311
[TBL] [Abstract][Full Text] [Related]
53. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial.
van der Made SM; Plat J; Mensink RP
PLoS One; 2015; 10(3):e0118393. PubMed ID: 25790328
[TBL] [Abstract][Full Text] [Related]
54. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.
Derosa G; Cicero AF; Fogari E; D'Angelo A; Bonaventura A; Romano D; Maffioli P
J Clin Lipidol; 2012; 6(6):553-64. PubMed ID: 23312051
[TBL] [Abstract][Full Text] [Related]
55. Acute effects of ghrelin administration on glucose and lipid metabolism.
Vestergaard ET; Djurhuus CB; Gjedsted J; Nielsen S; Møller N; Holst JJ; Jørgensen JO; Schmitz O
J Clin Endocrinol Metab; 2008 Feb; 93(2):438-44. PubMed ID: 18042651
[TBL] [Abstract][Full Text] [Related]
56. A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial.
Liu Y; Cotillard A; Vatier C; Bastard JP; Fellahi S; Stévant M; Allatif O; Langlois C; Bieuvelet S; Brochot A; Guilbot A; Clément K; Rizkalla SW
PLoS One; 2015; 10(9):e0138646. PubMed ID: 26406981
[TBL] [Abstract][Full Text] [Related]
57. Thermogenesis induced by a high-carbohydrate meal in fasted lean and overweight young men: insulin, body fat, and sympathetic nervous system involvement.
Marques-Lopes I; Forga L; Martínez JA
Nutrition; 2003 Jan; 19(1):25-9. PubMed ID: 12507635
[TBL] [Abstract][Full Text] [Related]
58. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial.
Canfora EE; van der Beek CM; Jocken JWE; Goossens GH; Holst JJ; Olde Damink SWM; Lenaerts K; Dejong CHC; Blaak EE
Sci Rep; 2017 May; 7(1):2360. PubMed ID: 28539646
[TBL] [Abstract][Full Text] [Related]
59. Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial.
Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
Am J Clin Nutr; 2016 Jan; 103(1):66-70. PubMed ID: 26607942
[TBL] [Abstract][Full Text] [Related]
60. Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate.
Lin L; Zeng L; Liu A; Yuan D; Peng Y; Zhang S; Li Y; Chen J; Xiao W; Gong Z
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
